All

Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and Bioactive Molecules
16 November 2016

Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and Bioactive Molecules

Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they...

Read the press release
Funding: Seventure Partners helps Fintech company Anytime raise 5M€
15 November 2016

Funding: Seventure Partners helps Fintech company Anytime raise 5M€

Anytime announces that its latest funding round has raised 5 million Euros. A leading European player in financing innovation, Seventure Partners deployed €4.5 million for...

Read the press release
Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products
2 November 2016

Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products

Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear medicine, announced today that the...

Read the press release
Murata to acquire IPDiA, a leader in high performance silicon capacitors
12 October 2016

Murata to acquire IPDiA, a leader in high performance silicon capacitors

Murata Manufacturing Co., Ltd., (“Murata”) and IPDiA S.A.(“IPDiA”) today announced that Murata Electronics Europe B.V., a wholly-owned subsidiary of Murata is about to...

Read the press release
WEBHELP EXPANDS SOCIAL EXPERTISE WITH ACQUISITION OF LEADING SOCIAL CONTENT MODERATION FIRM NETINO
4 October 2016

WEBHELP EXPANDS SOCIAL EXPERTISE WITH ACQUISITION OF LEADING SOCIAL CONTENT MODERATION FIRM NETINO

Leading global customer experience company, Webhelp, has announced the acquisition of top social content moderation company, Netino.
Headquartered in Paris, France,...

Read the press release
MOBILE PAYMENT COMPANIES SUMUP AND PAYLEVEN ANNOUNCE MERGER
27 April 2016

MOBILE PAYMENT COMPANIES SUMUP AND PAYLEVEN ANNOUNCE MERGER

Mobile payment companies SumUp & payleven today announced a definitive merger agreement to create the global leader in mobile payments. The shareholders of both companies have...

Read the press release
Enterome raises €14.5 million in Series C financing round Nestlé Health Science invests alongside existing investors
20 April 2016

Enterome raises €14.5 million in Series C financing round Nestlé Health Science invests alongside existing investors

ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that it has raised €14.5 million in a Series C...

Read the press release
TargEDys develops new microbiome-based solutions for appetite regulation and announces a €5.8M international round of financing to demonstrate product clinical efficacy.
14 April 2016

TargEDys develops new microbiome-based solutions for appetite regulation and announces a €5.8M international round of financing to demonstrate product clinical efficacy.

TargEDys, an innovator in appetite regulation, announces a €5.8M “Series A” fundraising round based on world-leading research from company founders Serguei Fetissov and...

Read the press release
Cambrooke Therapeutics, Inc. Secures Series C Funding Led by Paris-based Seventure Partners
11 April 2016

Cambrooke Therapeutics, Inc. Secures Series C Funding Led by Paris-based Seventure Partners

Cambrooke Therapeutics, Inc. (“Cambrooke”), a global therapeutic nutrition innovator, is pleased to announce the closing of the Series C investment round, led by Seventure...

Read the press release
MaaT Pharma announces €10 million fundraising and pursues the development of the first worldwide autologous microbiotherapy solution
22 March 2016

MaaT Pharma announces €10 million fundraising and pursues the development of the first worldwide autologous microbiotherapy solution

MaaT Pharma, a reference for the microbiome industry, is announcing a significant €10 million fundraising operation within the context of its series A. This will notably...

Read the press release